Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
OVERLAP
33%
OVERLAP
BY WEIGHT
13
# OF OVERLAPPING
HOLDINGS
HRTS
43
HOLDINGS
30%
ALSO IN CANC
CANC
50
HOLDINGS
26%
ALSO IN HRTS
SECTOR DRIFT (HRTS minus CANC)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in HRTS |
Weight in CANC |
Overlap | |
|---|---|---|---|---|
 |
ROCHE HOLDINGS LTD-SPONS ADR | 4.3% | 4.9% | 4.3% |
 |
ASTRAZENECA PLC | 4.4% | 4.3% | 4.3% |
 |
ELI LILLY & CO | 7.4% | 3.6% | 3.6% |
|
NOVARTIS AG | 3.2% | 4.2% | 3.2% |
|
BRIDGEBIO PHARMA, INC. | 3.0% | 5.2% | 3.0% |
HRTS Overweight Relative to CANC
|
ABBOTT LABORATORIES | 5.1% |
|
UNITEDHEALTH GROUP INC | 4.1% |
|
ELI LILLY & CO | 3.8% |
 |
MEDTRONIC PLC | 3.7% |
|
BOSTON SCIENTIFIC CORP | 3.6% |
 |
NOVO NORDISK A/S-B | 3.4% |
|
THERMO FISHER SCIENTIFIC INC | 3.3% |
|
VERTEX PHARMACEUTICALS INC | 2.6% |
|
ALNYLAM PHARMACEUTICALS INC | 2.5% |
|
CRINETICS PHARMACEUTICALS INC | 2.5% |
HRTS Underweight Relative to CANC
 |
MERUS N.V. | -4.5% |
|
REVOLUTION MEDICINES, INC. | -4.3% |
|
SUMMIT THERAPEUTICS INC | -4.2% |
|
GENMAB A/S SPONSORED ADR | -3.8% |
|
EXELIXIS INC | -3.4% |
|
ARCELLX, INC. | -3.3% |
|
NUVALENT, INC. CLASS A | -3.2% |
 |
ZAI LAB LTD. UNSPONSORED ADR | -3.1% |
|
BEIGENE LTD. SPONSORED ADR | -3.0% |
|
LEGEND BIOTECH CORPORATION SPONSORED | -2.9% |